RNS Number : 7769B
Medgenics Inc
02 November 2009
Medgenics, Inc.
('Medgenics' or the 'Company')
2 November 2009
The Board of Medgenics announces that on 30 October 2009 Mr. Joel Kanter (a Director of the Company) informed the Company that on 30 October he acquired in the market 25,000 common shares of par value US$ 0.0001 each ("Common Shares") in the Company at a price of 9.2 pence per Common Share.
The total interest in Shares of Mr. Kanter and his related parties following this purchase is 14,078,397 Common Shares representing approximately 11.5 % of the issued share capital of the Company (excluding his interest in warrants, options and convertible debentures as previously announced).
For further information, contact:
|
Medgenics, Inc.
Dr. Andrew L. Pearlman
|
Phone: +972 4 902 8900
|
|
Grayling (Financial PR, UK)
Jonathan Shillington
Alistair Scott
|
Phone: +44 7900 053 536
jonathan.shillington@uk.grayling.com
|
|
Blomfield Corporate Finance Limited (Nominated Adviser)
James Pinner
Alan MacKenzie
|
Phone: +44 207 444 0800
|
|
SVS Securities plc (Broker)
Ian Callaway
|
Phone: +44 207 638 5600
|
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEAAFAEFPNFFE